Real-World Evidence (RWE) Tracker

A Big Pharma client was interested in running analysis to understand competitor real-world evidence (RWE) activities psoriatic arthritis (PsA), in order to assess how competitors are generating & using RWE data to support the success of their late-stage & marketed assets

Our Solution

GlobalData leveraged is established RWE Tracker methodology to monitor RWE generation (RWE study designs, conference abstracts, journal publications) & commercial utilization (company sponsored presentations & exhibit booth content at conferences, press releases, websites) over the past 5 years, across a range of key metrics that are captured in database & report format:

  • Indirect comparison of RWE vs. label data
  • Key registry studies
  • Key RWE timeline
  • Most analyzed registries
  • RWE sponsors
  • Key country-specific RWE
  • RWE featuring key words
  • Size of registry
  • Real-world cost-effectiveness data
  • RWE featuring in company conference commercial activities
  • Recent & ongoing RWE studies
  • Publications & abstracts

Outcome

GlobalData provided the client with RWE database updates & presentations throughout the 12-month project following key rheumatology congresses (EULAR & ACR), in addition to providing a full report update in both Excel database, PowerPoint report, & webinar formats.

Client feedback

“As with the Lupus information [real-world evidence CI tracking project], I found the PsA [psoriatic arthritis] info very informative and it even immediately helped to inform the design of a study I had been planning. So, thank-you again for pulling this together.”

DECODED Your daily industry news round-up

This site is registered on wpml.org as a development site.